Literature DB >> 16214080

C-reactive protein: ligands, receptors and role in inflammation.

Lorraine Marnell1, Carolyn Mold, Terry W Du Clos.   

Abstract

C-reactive protein (CRP) is the prototypical acute phase serum protein, rising rapidly in response to inflammation. CRP binds to phosphocholine (PC) and related molecules on microorganisms and plays an important role in host defense. However, a more important role may be the binding of CRP to PC in damaged membranes. CRP increases clearance of apoptotic cells, binds to nuclear antigens and by masking autoantigens from the immune system or enhancing their clearance, CRP may prevent autoimmunity. CRP binds to both the stimulatory receptors, FcgammaRI and FcgammaRIIa, increasing phagocytosis and the release of inflammatory cytokines; and to the inhibitory receptor, FcgammaRIIb, blocking activating signals. We have shown that, in two animal models of systemic lupus erythematosus (SLE), the (NZB x NZW)F1 mouse and the MRL/lpr mouse, a single injection of CRP before onset of proteinuria delayed disease development and late treatment reversed proteinuria. Thus, in these models, CRP plays an anti-inflammatory role.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16214080     DOI: 10.1016/j.clim.2005.08.004

Source DB:  PubMed          Journal:  Clin Immunol        ISSN: 1521-6616            Impact factor:   3.969


  179 in total

1.  C-reactive protein-mediated vascular injury requires complement.

Authors:  Fadi G Hage; Suzanne Oparil; Dongqi Xing; Yiu-Fai Chen; Mark A McCrory; Alexander J Szalai
Journal:  Arterioscler Thromb Vasc Biol       Date:  2010-03-25       Impact factor: 8.311

2.  Alkaline phosphatase and percentage body fat predict circulating C-reactive protein in premenopausal women.

Authors:  Fatima Nayeem; Karl E Anderson; Manubai Nagamani; James J Grady; Lee-Jane W Lu
Journal:  Biomarkers       Date:  2010-09-29       Impact factor: 2.658

3.  CRP can play both pro-inflammatory and anti-inflammatory roles.

Authors:  Irving Kushner; Alok Agrawal
Journal:  Mol Immunol       Date:  2006-03-15       Impact factor: 4.407

Review 4.  Recent insights into the genetic basis of systemic lupus erythematosus.

Authors:  K L Moser; J A Kelly; C J Lessard; J B Harley
Journal:  Genes Immun       Date:  2009-05-14       Impact factor: 2.676

Review 5.  Adjunct corticosteroid treatment in patients with pneumonia: A precision medicine approach.

Authors:  Srdjan Gavrilovic; Ana Andrijevic; Aida Mujakovic; Yewande Odeyemi; Belma Paralija; Ognjen Gajic
Journal:  Bosn J Basic Med Sci       Date:  2019-11-08       Impact factor: 3.363

Review 6.  The protective function of human C-reactive protein in mouse models of Streptococcus pneumoniae infection.

Authors:  Alok Agrawal; Madathilparambil V Suresh; Sanjay K Singh; Donald A Ferguson
Journal:  Endocr Metab Immune Disord Drug Targets       Date:  2008-12       Impact factor: 2.895

7.  C-reactive protein (CRP) polymorphisms and haplotypes are associated with SLE susceptibility and activity but not with serum CRP levels in Mexican population.

Authors:  Yemil Atisha-Fregoso; Guadalupe Lima; Eduardo Carrillo-Maravilla; Rosalinda Posadas-Sánchez; Nonanzit Pérez-Hernández; Miguel Baños-Peláez; Alejandra Iturralde-Chávez; Nora Hernández-Díaz; Juan Jakez-Ocampo; José Manuel Rodríguez-Pérez; Gilberto Vargas-Alarcón; Luis Llorente; Juanita Romero-Díaz
Journal:  Clin Rheumatol       Date:  2018-03-20       Impact factor: 2.980

8.  C-reactive protein +1444CT (rs1130864) genetic polymorphism is associated with the susceptibility to systemic lupus erythematosus and C-reactive protein levels.

Authors:  Francieli Delongui; Marcell Allyson Batisti Lozovoy; Tatiana Mayiumi Veiga Iriyoda; Neide Tomimura Costa; Nicole Perugini Stadtlober; Daniela Frizon Alfieri; Tamires Flauzino; Isaias Dichi; Andréa Name Colado Simão; Edna Maria Vissoci Reiche
Journal:  Clin Rheumatol       Date:  2017-06-01       Impact factor: 2.980

9.  Legionella pneumophila DNA in serum samples during Legionnaires' disease in relation to C-reactive protein levels.

Authors:  F L van de Veerdonk; C P C de Jager; J J A Schellekens; C J J Huijsmans; F Beaumont; M H A Hermans; P C Wever
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2008-10-15       Impact factor: 3.267

10.  The Glasgow Prognostic Score (GPS) is a novel prognostic indicator in advanced epithelial ovarian cancer: a multicenter retrospective study.

Authors:  Jiayu Zhu; Hua Wang; Cheng-Cheng Liu; Yue Lu; Hailin Tang
Journal:  J Cancer Res Clin Oncol       Date:  2016-08-26       Impact factor: 4.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.